Home Contact Center Add this

The Staphylococcal-specific Antibiotic Debio 1450 Minimizes Disturbance to the Gut Microbiota in Mice

29 October 2016

J. Kuehn (1), F. Wittke (1), M. Barbier (1), S. Le Fresne (2), T. Carton (2), S. Leuillet (2), F. Le Vacon (2), G. Vuagniaux (1)

pdfPresented at IDWeek 2016, New Orleans, LA, USA

  1. Debiopharm International SA, Switzerland;
  2. Biofortis Mérieux NutriSciences, France.